首页|氟西汀结合生物反馈治疗躯体形式障碍患者疗效及心理状态的变化

氟西汀结合生物反馈治疗躯体形式障碍患者疗效及心理状态的变化

扫码查看
目的 探究氟西汀结合生物反馈治疗对躯体形式障碍患者疗效及心理状态的改善效果.方法 选取2020年7月至2021年6月108例衡水市第七人民医院收治的躯体形式障碍患者为研究对象,随机数表法分为氟西汀治疗组(氟西汀治疗,54例)与氟西汀联合生物反馈治疗组(氟西汀联合生物反馈治疗,54例),同期招募108名健康志愿者为对照组.比较三组心率变异性(HRV)各指标差异,比较氟西汀治疗组与氟西汀联合生物反馈治疗组治疗前后的心理状态变化情况,并记录治疗期间不良反应发生情况.结果 治疗8周后,治疗的两组SCL-90、SSS、HAMA评分均下降,且氟西汀联合生物反馈治疗组SCL-90、SSS、HAMA评分低于氟西汀治疗组,差异有统计学意义(t=2.361、3.859、12.329,P<0.05).氟西汀治疗组及氟西汀联合生物反馈治疗组HF、LF、LF/HF均低于对照组,HF%、LF%高于对照组,差异均具有统计学意义(F=331.611、757.501、80.773、33.151、410.655,P<0.05).治疗8周后,两组HF、LF、HF%、LF%水平均升高,LF/HF降低,且氟西汀联合生物反馈治疗组HF、LF、LF/HF水平高于氟西汀治疗组,HF%、LF%低于氟西汀治疗组,差异有统计学意义(t=6.417、6.075、3.917、5.738、2.206,P<0.05).结论 与单用氟西汀治疗相比,采用氟西汀结合生物反馈治疗可有效改善躯体形式障碍患者心理状态,调节自主神经系统活性,疗效及安全性均较好.
Efficacy and changes in psychological state of patients with somatoform disorders treated with fluoxetine combined with biofeedback
Objective To explore the efficacy of fluoxetine combined with biofeedback therapy in patients with somatoform disorders and the improvement of psychological state. Methods A total of 108 pa-tients with somatic form disorder were admitted to Hengshui Seventh People's Hospital from July 2020 to June 2021 and were selected as the study subjects. They were divided into two groups:the fluoxetine treatment group(fluoxetine treatment,54 cases)and the fluoxetine combined with biofeedback treatment group(54 cas-es)using a random number table method. Additionally,during the same period,108 healthy volunteers were recruited as the control group. The differences in heart rate variability (HRV) among the three groups were compared. The changes in mental state before and after treatment between the fluoxetine treatment group and the fluoxetine combined with biofeedback treatment group were compared ,any occurrences of adverse reac-tions during treatment were recorded. Results After 8 weeks of treatment,the scores of SCL-90,SSS and HAMA in both groups decreased. The scores of SCL-90,SSS and HAMA in the fluoxetine combined with bio-feedback treatment group were lower than those in the fluoxetine treatment group ,with statistical significance (t=2.361,3.859,12.329,P<0.05). HF,LF and LF/HF in both the fluoxetine treatment group and the fluox-etine combined with biofeedback treatment group were lower than those in the control group. HF% and LF%were higher than those in the control group,with statistical significance (F=331.611,757.501,80.773, 33.151,410.655,P<0.05). After 8 weeks of treatment,the levels of HF,LF,HF% and LF% increased and LF/HF decreased in both groups. The HF,LF and LF/HF levels in the fluoxetine combined with biofeedback treatment group were higher than those in the fluoxetine treatment group ,while the HF%and LF%were lower than those in the fluoxetine treatment group. The difference was statistically significant (t=6.417,6.075, 3.917,5.738,2.206,P<0.05). Conclusion Compared to fluoxetine alone,fluoxetine combined with bio-feedback therapy can effectively improve the psychological state of patients with somatoform disorders. It can also regulate the activity of the autonomic nervous system ,leading to better efficacy and safety.

FluoxetineBiofeedback therapySomatoform disordersHeart rate variability

郑荫荫、李倩、王磊、孟祥生、徐从恩

展开 >

河北省衡水市第七人民医院精神科,河北,衡水053800

河北省衡水市第七人民医院功能科,河北,衡水053800

氟西汀 生物反馈治疗 躯体形式障碍 心率变异性

河北省医学科学研究项目

20211503

2024

分子诊断与治疗杂志
中山大学

分子诊断与治疗杂志

CSTPCD
影响因子:0.65
ISSN:1674-6929
年,卷(期):2024.16(3)
  • 14